The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Diflunisal Analogues Stabilize the Native State of Transthyretin. Potent Inhibition of Amyloidogenesis
Abstract
Analogues of diflunisal, an FDA-approved nonsteroidal antiinflammatory drug (NSAID), were synthesized and evaluated as inhibitors of transthyretin (TTR) aggregation, including amyloid fibril formation. High inhibitory activity was observed for 26 of the compounds. Of those, eight exhibited excellent binding selectivity for TTR in human plasma (binding stoichiometry >0.50, with a theoretical maximum of 2.0 inhibitors bound per TTR tetramer). Biophysical studies reveal that these eight inhibitors dramatically slow tetramer dissociation (the rate-determining step of amyloidogenesis) over a duration of 168 h. This appears to be achieved through ground-state stabilization, which raises the kinetic barrier for tetramer dissociation. Kinetic stabilization of WT TTR by these eight inhibitors is further substantiated by the decreasing rate of amyloid fibril formation as a function of increasing inhibitor concentration (pH 4.4). X-ray cocrystal structures of the TTR.18(2) and TTR.20(2) complexes reveal that 18 and 20 bind in opposite orientations in the TTR binding site. Moving the fluorines from the meta positions in 18 to the ortho positions in 20 reverses the binding orientation, allowing the hydrophilic aromatic ring of 20 to orient in the outer binding pocket where the carboxylate engages in favorable electrostatic interactions with the epsilon-ammonium groups of Lys 15 and 15'. The hydrophilic aryl ring of 18 occupies the inner binding pocket, with the carboxylate positioned to hydrogen bond to the serine 117 and 117' residues. Diflunisal itself appears to occupy both orientations based on the electron density in the TTR.1(2) structure. Structure-activity relationships reveal that para-carboxylate substitution on the hydrophilic ring and dihalogen substitution on the hydrophobic ring afford the most active TTR amyloid inhibitors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting small Aβ oligomers: the solution to an Alzheimer's disease conundrum?
Klein, W. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01749-5 · Cited by 989
Research works printed but not linked: 79
- Colon W., 1992, Biochemistry, 31, 60, 10.1021/bi00151a036 · DOI · Paper page
- Kelly J. W, 1996, Curr. Opin. Struct. Biol., 6, 7, 10.1016/S0959-440X(96)80089-3 · DOI · Paper page
- Liu K., 2000, Nat. Struct. Biol., 7, 7, 10.1038/71197 · DOI
- Westermark P., 1990, Proc. Natl. Acad. Sci. U.S.A., 87, 5
- Saraiva M. J., 1985, J. Clin. Invest., 76, 7, 10.1172/JCI112224 · DOI
- Jacobson D. R., 1997, Late-Onset Cardiac Amyloidosis in Black Americans N. Engl. J. Med., 336, 73
- Buxbaum J. N., 2000, Annu. Rev. Med., 51, 569, 10.1146/annurev.med.51.1.543 · DOI
- Saraiva M. J, 1995, Hum. Mutat., 5, 6
- Blake C. C., 1978, J. Mol. Biol., 121, 56, 10.1016/0022-2836(78)90368-6 · DOI · Paper page
- Wojtczak A., 1996, Acta Crystallogr., Sect. D, 758, 810
- Monaco H. L., 1995, Science, 268, 41, 10.1126/science.7754382 · DOI · Paper page
- Lai Z., 1996, Biochemistry, 35, 82
- Holmgren G., 1993, Lancet, 341, 6, 10.1016/0140-6736(93)93127-M · DOI · Paper page
- Suhr O. B., 2002, Liver Transpl., 8, 94
- Dubrey S. W., 1997, Transplantation, 64, 80, 10.1097/00007890-199707150-00014 · DOI · Paper page
- Yazaki M., 2000, Biochem. Biophys. Res. Commun., 274, 6, 10.1006/bbrc.2000.3203 · DOI · Paper page
- Cornwell C. G., 1983, Am. J. Med., 75, 623, 10.1016/0002-9343(83)90443-6 · DOI · Paper page
- Miroy G. J., 1996, Proc. Natl. Acad. Sci. U.S.A., 93, 6, 10.1073/pnas.93.26.15051 · DOI · Paper page
- Klabunde T., 2000, Nat. Struct. Biol., 7, 21
- Baures P. W., 1998, Bioorg. Med. Chem., 6, 401, 10.1016/S0968-0896(98)00130-8 · DOI
- Petrassi H. M., 2000, J. Am. Chem. Soc., 122, 2192, 10.1021/ja993309v · DOI
- Baures P. W., 1999, Bioorg. Med. Chem., 7, 47, 10.1016/S0968-0896(99)00066-8 · DOI
- Sacchettini J. C., 2002, Nat. Rev. Drug Discuss., 1, 275
- Oza V. B., 2002, J. Med. Chem., 45, 32, 10.1021/jm0110082 · doi:10.1021/jm0110082
- Hammarstrom P., 2003, Science, 299, 716, 10.1126/science.1079589 · DOI · Paper page
- Bartalena L., 1993, Clin. Lab. Med., 13, 98, 10.1016/S0272-2712(18)30427-X · DOI
- Aldred A. R., 1995, Comp. Biochem. Physiol. B Biochem. Mol. Biol., 111, 15, 10.1016/0305-0491(94)00229-N · DOI
- Mao H. Y., 2001, J. Am. Chem. Soc., 123, 10435
- Blake C. C., 1977, Nature, 268, 20
- Verbeeck R. K., 1980, Biochem. Pharm., 29, 576, 10.1016/0006-2952(80)90378-0 · doi:10.1016/0006-2952(80)90378-0
- Nuernberg B., 1991, Clin. Pharmacokin., 20, 89, 10.2165/00003088-199120010-00006 · doi:10.2165/00003088-199120010-00006
- Miyaura N., 1981, Synth. Commun., 11, 519, 10.1080/00397918108063618 · DOI · Paper page
- Sharp M. J., 1985, Tetrahedron Lett., 26, 6000, 10.1016/S0040-4039(00)95108-6 · doi:10.1016/s0040-4039(00)95108-6
- Sharp M. J., 1987, Tetrahedron Lett., 28, 5096, 10.1016/S0040-4039(00)95599-0 · doi:10.1016/s0040-4039(00)95599-0
- Pozsgay V., 1981, Carbohydr. Res., 90, 231, 10.1016/S0008-6215(00)85921-2 · doi:10.1016/s0008-6215(00)85921-2
- Guiles J. W., 1996, Org. Chem., 61, 5171, 10.1021/jo9604301 · doi:10.1021/jo9604301
- Nicolaou K. C., 1999, Chem. Eur. J., 5, 2621
- Chu-Moyer M. Y., 2002, J. Med. Chem., 45, 528
- Song X. P., 2002, Org. Lett., 4, 552
- Nicolaou K. C., 2001, J. Am. Chem. Soc., 123, 9323, 10.1021/ja011338b · doi:10.1021/ja011338b
- Purkey H. E., 2001, Proc. Natl. Acad. Sci. U.S.A., 98, 71, 10.1073/pnas.091431798 · DOI
- Steelman S. L., 1978, Current Med. Res. Opin., 5, 514, 10.1185/03007997809108993 · doi:10.1185/03007997809108993
- Hammarstrom P., 2002, Proc. Natl. Acad. Sci. U.S.A., 25, 32
- Hammarstrom P., 2001, Biochemistry, 40, 11459, 10.1021/bi010673+ · DOI
- Ma J., 2002, Science, 298, 1788, 10.1126/science.1077123 · DOI · Paper page
- Walsh D. M. K. I., 2002, Nature, 416, 539, 10.1038/416539a · DOI · Paper page
- Bucciantini M. G. E., 2002, Nature, 416, 511
- Lashuel H. A., 2002, Nature, 418, 291, 10.1038/418291a · DOI · Paper page
- Otwinowski Z., 1997, Methods in Enzymology, 276, 326
- Kissinger C. R., 1999, Acta Crystallogr., Sect. D, 55, 491, 10.1107/S0907444998012517 · DOI · Paper page
- Brunger A. T., 1998, Acta Crystallogr., Sect. D, 54, 921, 10.1107/S0907444998003254 · DOI · Paper page
- Kantardjieff K., 2002, Acta Crystallogr., Sect. D, 58, 743, 10.1107/S0907444901019588 · doi:10.1107/s0907444901019588
- Bailey S, 1994, Acta Crystallogr., Sect. D, 50, 763, 10.1107/S0907444993011898 · DOI · Paper page
- Murshudov G. N., 1997, Acta Crystallogr., Sect. D, 53, 255, 10.1107/S0907444996012255 · DOI · Paper page
- Lashuel H. A., 1998, Biochemistry, 37, 64, 10.1021/bi981876+ · DOI · Paper page
- Lashuel H. A., 1999, Biochemistry, 38, 73, 10.1021/bi991021c · DOI · Paper page
- Johansson G., 1997, J. Med. Chem., 40, 3819, 10.1021/jm970346t · doi:10.1021/jm970346t
- Corey E. J., 1985, J. Am. Chem. Soc., 107, 5576, 10.1021/ja00305a068 · doi:10.1021/ja00305a068
- Chambers R. D., 2000, J. Fluorine Chem., 102, 174, 10.1016/S0022-1139(99)00238-9 · doi:10.1016/s0022-1139(99)00238-9
- Li J., 1996, J. Med. Chem., 39, 1856
- Jendralla H., 1990, Synthesis, 827, 833
- Kelm J., 1981, Spectrochim. Acta, Part A, 37, 692, 10.1016/0584-8539(81)80068-2 · doi:10.1016/0584-8539(81)80068-2
- Bumagin N. A., 1997, Tetrahedron, 53, 14450, 10.1016/S0040-4020(97)00936-8 · doi:10.1016/s0040-4020(97)00936-8
- Ananthakrishnanadar P., 1982, J. Chem. Soc., Perkin Trans. 2, 1305, 1308
- Homsi F., 2000, Tetrahedron Lett., 41, 5872, 10.1016/S0040-4039(00)00789-9 · doi:10.1016/s0040-4039(00)00789-9
- Hajduk P. J., 1997, J. Med. Chem., 40, 3150, 10.1021/jm9703404 · DOI · Paper page
- Patrick T. B., 1985, J. Org. Chem., 50, 2235, 10.1021/jo00213a007 · doi:10.1021/jo00213a007
- Kuchar M., 1988, Coll. Czech. Chem. Commun., 53, 1872, 10.1135/cccc19881862 · doi:10.1135/cccc19881862
- Allen K. J., 1983, J. Chem. Soc., Perkin Trans. 2, 691, 695
- Nakada M., 1989, Bull. Chem. Soc. Jpn., 62, 3126
- Weingarten H, 1961, J. Org. Chem., 26, 733, 10.1021/jo01062a022 · doi:10.1021/jo01062a022
- Hashizume H., 1994, Chem. Pharm. Bull., 42, 520
- Indolese A. F, 1997, Tetrahedron Lett., 38, 3516, 10.1016/S0040-4039(97)00707-7 · doi:10.1016/s0040-4039(97)00707-7
- Pridgen L. N., 1989, J. Org. Chem., 54, 1526, 10.1021/jo00268a010 · doi:10.1021/jo00268a010
- Huang C. G., 1991, J. Am. Chem. Soc., 113, 7684, 10.1021/ja00020a034 · doi:10.1021/ja00020a034
- Wendeborn S., 1998, Synlett., 6, 675
- Stevens C. V., 2001, Tetrahedron, 57, 7870
- Tanaka K., 1990, J. Org. Chem., 55, 2983, 10.1021/jo00296a085 · doi:10.1021/jo00296a085
- Clive D. L. J., 2001, J. Org. Chem., 66, 6091
Cited by
Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade
Bulawa, C. E., Connelly, S., DeVit, M., Wang, L., Weigel, C., Fleming, J. A., Packman, J., Powers, E. T., Wiseman, R. L., Foss, T. R., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121005109 · Cited by 742
Self-citationAlonso, F., Beletskaya, I. P., & Yus, M. (2008) · Tetrahedron · doi:10.1016/j.tet.2007.12.036 · Cited by 532
Alonso, F., Beletskaya, I. P., & Yus, M. (2005) · Tetrahedron · doi:10.1016/j.tet.2005.08.054 · Cited by 498
Modulators of Protein–Protein Interactions
Milroy, L.-G., Grossmann, T. N., Hennig, S., Brunsveld, L., & Ottmann, C. (2014) · Chemical Reviews · doi:10.1021/cr400698c · Cited by 497
Johnson, S. M., Connelly, S., Fearns, C., Powers, E. T., & Kelly, J. W. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.12.060 · Cited by 328
Self-citation
Metadata
- Authors
- Adamski-Werner, S. L., Palaninathan, S. K., Sacchettini, J. C., & Kelly, J. W.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2003-12-11
- Volume
- 47
- Issue
- 2
- Pages
- 355-374
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W1987063515
- Cited by
- 230
- References
- 1
- FWCI
- 2.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Diflunisal Analogues Stabilize the Native State of Transthyretin. Potent Inhibition of Amyloidogenesis. https://app.cochat.ai/papers/10.1021/jm030347n
- The paper
- Adamski-Werner, S. L., Palaninathan, S. K., Sacchettini, J. C., & Kelly, J. W. (2004). Diflunisal Analogues Stabilize the Native State of Transthyretin. Potent Inhibition of Amyloidogenesis. Journal of Medicinal Chemistry. https://doi.org/10.1021/jm030347n
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.